News Center
- Details
- Details
-
The factory building project of the second phase of Fujian Three Gorges Offshore Wind Power Industrial Park passed completion acceptanceDetails
The factory building project of the second phase of Fujian Three Gorges Offshore Wind Power Industrial Park passed completion acceptance
-
Global Times: China's environmental protection efforts benefit whole Asia regionDetails
BEIJING,Nov. 19,2024-- China\'s continuous improvement of air quality and reduction of greenhouse gas emissions has benefited not only the country itself,but also the rest of Asia and the world,foreig
-
RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors DevelopmentDetails
BEIJING,Nov. 19,2024-- With the support of the RiDYMO® platform,we are able to comprehensively explore various potential targets in drug development,including protein-protein interactions,kinases,
-
Colt Data Centre Services and RMZ announce a joint venture to invest $1.7 Billion in the Indian Data Centre marketDetails
The investment will initially focus on expediting development at existing sites inNavi Mumbai and Ambattur,Chennai,with an additional third site to be added in future.
-
Pop Culture Announces Improvement in Overall Operations During the Fiscal Year Ended June 30, 2024Details
XIAMEN,China,Nov. 19,2024-- In the fiscal year ended June 30,2024,POP CULTURE GROUP CO.,LTD. ("Pop Culture," or the "Company," Nasdaq: CPOP) continued to focus on its three busines
-
Brii Bio Delivers First Head-to-Head Comparison of siRNA (Elebsiran) and PEG-IFNα Combination versus PEG-IFNα Alone at AASLD's The Liver Meeting® 2024, Demonstrating Higher Loss of HBV Surface Antigen by Combining with siRNADetails
48-week end-of-treatment data from theongoing Phase 2 ENSURE study clearly demonstrated the added benefits of elebsiran towards achieving a higher functional cure rate in combination with PEG-IFNα
-
Neo4j Surpasses $200M in Revenue, Accelerates Leadership in GenAI-Driven Graph TechnologyDetails
Database pioneer continues to scale at $2B+ valuation as GenAI accelerates demand SAN MATEO,Calif.,Nov. 19,2024--Neo4j®,the world\'s leading graph database and analytics company,announced that it
-
Ractigen Therapeutics Announces FDA Orphan Drug Designation for RAG-21 for the Treatment of ALSDetails
NANTONG and SUZHOU,China,Nov. 19,2024-- Ractigen Therapeutics,a clinical-stage pharmaceutical company dedicated to developing innovative therapies,today announced that the U.S. Food and Drug Administr
